| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5279057 | Tetrahedron Letters | 2005 | 4 Pages |
Abstract
A novel synthesis is described of the clinical trial prodrug ZD2767P that improves the overall yield from 13% to 45%.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Dan Niculescu-Duvaz, Ian Scanlon, Ion Niculescu-Duvaz, Caroline J. Springer,
![First Page Preview: A higher yielding synthesis of the clinical prodrug ZD2767P using di-protected 4-[N,N-bis(2-hydroxyethyl)amino]phenyl chloroformate A higher yielding synthesis of the clinical prodrug ZD2767P using di-protected 4-[N,N-bis(2-hydroxyethyl)amino]phenyl chloroformate](/preview/png/5279057.png)